[Elsevier] Efficacy and safety of fuzuloparib combined with bevacizumab as maintenance treatment for PARP inhibitor-pretreated platinum-sensitive recurrent ovarian cancer: a phase II study |
|
This post will be closed automatically in 2026-10-06 12:27
Reward30points
|
post
reply
points
1200
20
Combined associations of triglyceride-glucose index and biochemical sarcopenia index with cardiometabolic multimorbidity in middle-aged and older Chinese adults
10
Site selection for nature-based solutions for stormwater management in urban areas: An approach combining GIS and multi-criteria analysis
10
Comparison of new two-step calcium carbide production process and traditional production process using numerical simulation of heat transfer and chemical reaction
10
AI governance at work: Threat appraisal, work experience, and satisfaction with job, health, and financial situation
30
Extraction of characteristic information from financial super-long texts and prediction of corporate violations
